Neuropathic pain | From mechanism to management
| Saturday, May 30, 2026 |
| 12:00 PM - 12:30 PM |
Overview
Emeritus Prof Jeff Hughes
Details
Neuropathic pain affects around 7% to 10% of the general adult population worldwide and remains challenging to manage, with variable presentations and often limited response to treatment. For many, management can feel like trial and error rather than a clear, structured approach.
This session will define what neuropathic pain is and its different forms, provide an overview of the evidenced-base management of neuropathic pain and the place of multidisciplinary care and future initiatives.
Learning objectives:
- Identify what neuropathic is and describe its common features
- Discuss treatment options based on their efficacy (NNT) and safety (NNH) taking into consideration the underlying cause of the pain
- Discuss the rationale for phenotyping neuropathic pain in the personalisation of its management
Competency Standards (2016): 1.6, 3.3, 3.5
Speaker
Emeritus Prof Jeff Hughes
Chief Scientific Officer
Painchek Ltd
Neuropathic pain | From mechanism to management
Biography
Jeff Hughes is an Emeritus Professor in the School of Diagnostics and Therapeutics at Curtin University, and the Chief Scientific Officer and Founder of PainChek Ltd. Jeff has practice in hospital, community, consultant, academic and industry as a pharmacist. He is q former Head, School of Pharmacy, Curtin University (2009-2014). He is a recognised leader in clinical pharmacy practice, education and research. He has received multiple state, national and international professional awards including the PSA 2025 Lifetime Achievement Award. Jeff has published over 300 peer-reviewed and professional papers and contributed to 39 books. His passion for innovation has lead him to his recent endeavours to improve pain in people who cannot tell you they are in pain.
